Why are drug prices so high? Investigating th...

What's your point? Communication expert Chris Fenning reveals how the first 60 seconds can make or break a workplace conversation — and shares a three-step framework to help you get it right. After, Modupe shares how you can put Chris' ideas into practice. Hosted on Acast. See ac ...  Show more

Climate strategist Joojin Kim spent years convincing banks across South Korea to stop funding coal, and it worked. Now he's aiming that same playbook at a new target: maritime shipping, a hidden engine of the global economy — and one of the world's dirtiest industries. He breaks ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...